Benzinga's Top Initiations
Analysts at Citigroup initiated coverage on shares of Ambit Biosciences (NASDAQ: AMBI) with a “buy” rating. The target price range for Ambit Biosciences is set to $13. Ambit Biosciences' shares closed at $7.79 on Friday.
Goldman Sachs initiated coverage on shares of CVR Refining (NASDAQ: CVRR) with a “neutral” rating. The target price for CVR Refining is set to $37. CVR Refining's shares closed at $30.48 on Friday.
Sterne Agee initiated coverage on shares of Semtech (NASDAQ: SMTC) with a “buy” rating. The target price for Semtech is set to $46. Semtech's stock closed at $35.78 on Friday.
Analysts at Bank of America initiated coverage on shares of Credit Acceptance (NASDAQ: CACC) with a “neutral” rating. The target price for Credit Acceptance is set to $121. Credit Acceptance's shares closed at $113.14 on Friday.
Latest Ratings for AMBI
|Dec 2013||BMO Capital||Upgrades||Market Perform||Outperform|
|Dec 2013||BMO Capital||Downgrades||Outperform||Market Perform|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.